Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Lipase Testing Market: By Type: Hepatic Lipase, Total Lipase, Pancreatic Lipase; By Technology: Spectrophotometric, ELISA; By End Use: Diagnostic Laboratories, Special Clinics, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Lipase Testing Market Outlook
The global lipase testing market is being aided by the rising lipase market, which is expected to grow at a CAGR of 5% in the forecast period of 2021-2026.
North America to Significantly Contribute to the Growth of the Lipase Testing Industry
North America is one of the leading regions in the industry and is expected to significantly contribute to the industry growth over the forecast period. The factors driving the growth of the industry in North America include the availability of advanced diagnostic facilities and the presence of developed healthcare infrastructure in the region. Meanwhile, the Asia Pacific is expected to witness a robust growth in the coming years. This can be attributed to the presence of a large patient pool, growing R&D activities, and the increasing government investments to develop the healthcare facilities in the region. Other regions, namely, Latin America and the Middle East and Africa are expected to provide lucrative growth opportunities for the market expansion in the forecast period.
Lipase Testing: Industry Definition and Segmentation
Lipase is an enzyme secreted by pancreas into the digestive tract. It breaks down fats into fatty acids and glycerol and helps in their digestion. For digestive system to function normally, the concentration of lipase should be 10–73 units per litre (U/L) for individuals over 16 years of age. Abnormally high levels of lipase in the blood indicate health conditions like pancreatic cancer, acute pancreatitis, chronic pancreatitis, and celiac disease, among others. Lipase testing is predominantly used for the initial diagnosis of pancreatic function; however, it can also be performed to monitor other health conditions.
Based on type, the market is divided into:
- Hepatic Lipase
- Total Lipase
- Pancreatic Lipase
- Others
By technology, the industry can be segmented into:
- Spectrophotometric
- ELISA
- Others
On the basis of end use, the industry is categorised into:
- Diagnostic Laboratories
- Special Clinics
- Hospitals
- Research Centres
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Growing Prevalence of Pancreatic Disorders and Increase in the Number of Diagnostic Facilities to Bolster the Growth of the Lipase Testing Industry
The rise in the number of diagnostic centres and the growing cases of pancreatic disorders are the major factors driving the growth of the lipase testing industry. The market is being supported by the rise in patient pool, changing dietary patterns, increasing sedentary lifestyles, growing incidences of pancreatic cancer, and developing healthcare facilities. As lipase testing also plays a crucial role in measuring lipase levels in biological samples, the growing research activities, and clinical trials across the globe are expected to further boost the industry growth over the forecast period.
Key Industry Players in the Global Lipase Testing Market
The report gives a detailed analysis of the following key players in the global lipase testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Creative Biomart Inc.
- LifeSpan BioSciences, Inc
- Fitzgerald Industries International
- Athenese-Dx Private Limited
- BioAssay Systems
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Lipase Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global Lipase Testing Historical Market (2016-2020)
8.3 Global Lipase Testing Market Forecast (2021-2026)
8.4 Global Lipase Testing Market by Type
8.4.1 Hepatic Lipase
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Total Lipase
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Pancreatic Lipase
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Others
8.5 Global Lipase Testing Market by Technology
8.5.1 Spectrophotometric
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 ELISA
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Others
8.6 Global Lipase Testing Market by End Use
8.6.1 Diagnostic Laboratories
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Special Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Hospitals
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Research Centres
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Others
8.7 Global Lipase Testing Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Creative Biomart Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 LifeSpan BioSciences, Inc
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Fitzgerald Industries International
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Athenese-Dx Private Limited
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 BioAssay Systems
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Lipase Testing Market: Key Industry Highlights, 2016 and 2026
2. Global Lipase Testing Historical Market: Breakup by Type (USD Million), 2016-2020
3. Global Lipase Testing Market Forecast: Breakup by Type (USD Million), 2021-2026
4. Global Lipase Testing Historical Market: Breakup by Technology (USD Million), 2016-2020
5. Global Lipase Testing Market Forecast: Breakup by Technology (USD Million), 2021-2026
6. Global Lipase Testing Historical Market: Breakup by End Use (USD Million), 2016-2020
7. Global Lipase Testing Market Forecast: Breakup by End Use (USD Million), 2021-2026
8. Global Lipase Testing Historical Market: Breakup by Region (USD Million), 2016-2020
9. Global Lipase Testing Market Forecast: Breakup by Region (USD Million), 2021-2026
10. North America Lipase Testing Historical Market: Breakup by Country (USD Million), 2016-2020
11. North America Lipase Testing Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Europe Lipase Testing Historical Market: Breakup by Country (USD Million), 2016-2020
13. Europe Lipase Testing Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Asia Pacific Lipase Testing Historical Market: Breakup by Country (USD Million), 2016-2020
15. Asia Pacific Lipase Testing Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Latin America Lipase Testing Historical Market: Breakup by Country (USD Million), 2016-2020.
17. Latin America Lipase Testing Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Middle East and Africa Lipase Testing Historical Market: Breakup by Country (USD Million), 2016-2020
19. Middle East and Africa Lipase Testing Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Global Lipase Testing Market Structure
Key Questions Answered in the Report
The global lipase testing market is expected to be aided by the rising lipase market, which projected to grow at a CAGR of 5% between 2021 and 2026.
The major drivers of the industry, such as the growing patient pool, growing sedentary lifestyle, availability of advanced diagnostic facilities, improving healthcare infrastructures, and growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing research activities to develop new drugs and increase in the number of clinical trials.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of lipase testing in the market are hepatic lipase, total lipase, and pancreatic lipase, among others.
The major technology segments of lipase testing in the industry are spectrophotometric and ELISA, among others.
The significant end use sectors in the market are diagnostic laboratories, special clinics, hospitals, and research centres, among others.
The major players in the industry are Creative Biomart Inc., LifeSpan BioSciences, Inc, Fitzgerald Industries International, Athenese-Dx Private Limited, and BioAssay Systems, among others.
Analyst Review
The global lipase testing market is being driven by the growing patient pool and lipase market. Aided by the rising research activities, the lipase market is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By type, the market is segmented into hepatic lipase, total lipase, and pancreatic lipase, among others. Based on technology, the industry is divided into spectrophotometric and ELISA, among others. On the basis of end use, the market is segmented into diagnostic laboratories, special clinics, hospitals, and research centres, among others. The major regional markets for lipase testing are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Creative Biomart Inc., LifeSpan BioSciences, Inc, Fitzgerald Industries International, Athenese-Dx Private Limited, and BioAssay Systems, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysSingle User License
$3199$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst SupportFree Update in 180 DaysFive User License
$4199$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Corporate License
$5199$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
Free Update in 180 Days
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsProthrombin Complex Concentrate (PCC) Market Size, Share, Report 2021-2026
Precision Medicine Market Size, Share, Analysis, Trends 2021-2026
Empty Capsules Market Size, Share, Analysis, Growth, Report 2020-2026
The global human insulin market attained USD 36 billion in 2020. The market is expected to grow at a CAGR of 4.7% in the forecast period of 2021-2026 to attain USD 48 billion by 2026.
Gastrointestinal Stromal Tumor Market Size, Share, Growth, Report 2021-2026
NEWSLETTER